Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge Daniel N. CagneyBrian M. AlexanderAyal A. Aizer Topic Review 11 July 2016 Pages: 389 - 393
SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis) Chanida VinayanuwattikunSiyamol MingmalairakShanop Shuangshoti Laboratory Investigation 11 July 2016 Pages: 395 - 403
Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role Elia GuadagnoMarialaura Del Basso De CaroFlavia Dones Laboratory Investigation 09 July 2016 Pages: 405 - 413
Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors Irena Srebotnik-KirbišClara Limbäck-Stokin Laboratory Investigation 12 July 2016 Pages: 415 - 422
Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma Yongxiao LiTao JiangQing Chang Laboratory Investigation 12 July 2016 Pages: 423 - 431
The effects of sequential treatments on hippocampal volumes in malignant glioma patients Shantell C. NolenBrian LeeDaniela A. Bota Clinical Study 08 July 2016 Pages: 433 - 441
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study Ralph SalloumTrent R. HummelRachid Drissi Clinical Study 27 June 2016 Pages: 443 - 451
Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors Deborah T. BlumenthalMichal YalonFelix Bokstein Clinical Study 04 July 2016 Pages: 453 - 460
Does the choice of antiepileptic drug affect survival in glioblastoma patients? Kristin M. Knudsen-BaasAnders EngelandJone F. Owe Clinical Study 04 July 2016 Pages: 461 - 469
The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma Arian LasockiFrank GaillardStephen L. Stuckey Clinical Study 13 July 2016 Pages: 471 - 478
Age alone is not a predictor for survival in glioblastoma Lucy GatelyAnna CollinsAnthony Dowling Clinical Study 12 July 2016 Pages: 479 - 485
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma Shiao-Pei WeathersXiaosi HanJohn F. de Groot Clinical Study 12 July 2016 Pages: 487 - 494
The clinical significance of fascin expression in a newly diagnosed primary glioblastoma Ki-Su ParkHye Won LeeJeong-Hyun Hwang Clinical Study 12 July 2016 Pages: 495 - 503
Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion Tomohiro KawaguchiYukihiko SonodaTeiji Tominaga Clinical Study 11 July 2016 Pages: 505 - 514
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study Magnus SabelGudrun FleischhackOn behalf of the SIOP-E Brain Tumour Group Clinical Study Open access 16 July 2016 Pages: 515 - 524
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis F. K. HollaT. J. PostmaJ. J. Heimans Clinical Study Open access 11 July 2016 Pages: 525 - 532
Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma Anne HertensteinThomas HielscherAntje Wick Clinical Study 15 July 2016 Pages: 533 - 539
Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors Victoria CheungDevorah SegalMatthias A. Karajannis Clinical Study 12 July 2016 Pages: 541 - 544
A cure is possible: a study of 10-year survivors of brain metastases Rupesh KotechaSally VogelSamuel T. Chao Clinical Study 25 July 2016 Pages: 545 - 555
Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy Jacob Y. ShinAidnag Z. Diaz Clinical Study 11 July 2016 Pages: 557 - 565
Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients Jacob Y. ShinAidnag Z. Diaz Clinical Study 11 July 2016 Pages: 567 - 575
Coexistence of MLH3 germline variants in colon cancer patients belonging to families with Lynch syndrome-associated brain tumors Francesca DuraturoRaffaella LiccardoPaola Izzo Letter to the Editor 11 July 2016 Pages: 577 - 578
Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg) Chi Tung ChoyChi Hang WongHerbert Ho Fung Loong Letter to the Editor 18 July 2016 Pages: 579 - 581